BRAIN CELL OR NERVE CELL-PROTECTING AGENT COMPRISING GINSENOSIDE Rb1

Title:

BRAIN CELL OR NERVE CELL-PROTECTING AGENT COMPRISING GINSENOSIDE Rb1

Document Type and Number:

Japanese Patent JP2000191539

Kind Code:

A

Abstract:

To obtain the subject compound for accelerating expression of cell death suppressing gene product Bcl-xL by containing ginsenoside Rb1.

This protective agent for brain cells and nerve cells is brought to contain ginsenoside Rb1 (a compound expressed by the formula). As a medicinal composition, a formulation for intravenous injections is preferable. The concentration of ginsenoside Rb1 is preferably a low concentration, particularly the concentration of an extracellular fluid is ≤1 ng/ml, preferably ≤1 pg/ml, more preferably ≤100 fg/ml. A dose per day is usually ≥0.1 mg, preferably 1 mg to 1 g, more preferably 10 mg to 0.1 g.

More Like This:

JP3983796	3α-Hydroxy-3β-Substitution-Pregnane Production Method
JPS56158727	SYNTHESIS OF ESTRONE AND ESTRONE DERIVATIVES
WO/2014/083512	PROCESS FOR PREPARATION OF ABIRATERONE ACETATE

Inventors:

SAKANAKA MASAHIRO
TANAKA JUNYA
SATO KOJI

Application Number:

JP36556098A

Publication Date:

July 11, 2000

Filing Date:

December 22, 1998

Export Citation:

Click for automatic bibliography generation Help

Assignee:

JAPAN SCIENCE & TECH CORP

International Classes:

C07J13/00; A61K9/08; A61K31/00; A61K31/70; A61K31/7028; A61K31/7034; A61K31/704; A61K31/715; A61P9/00; A61P9/02; A61P9/10; A61P25/00; A61P25/02; A61P25/16; A61P25/28; A61P37/00; C07J17/00; (IPC1-7): A61K31/704; A61P9/02; A61P9/10; A61P25/00; A61P25/02; A61P25/28; A61P25/16; A61P37/00

Attorney, Agent or Firm:

Norio Saeki

Previous Patent: SUPPRESSANT FOR LEUCOCYTE-VASCULAR ENDOTHELIAL CELL ADHESION

Next Patent: PHARMACOTHERAPY FOR RESTENOSIS